EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, IQVIA Holdings's enterprise value is $48,355 Mil.
IQVIA Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $3,305 Mil. Therefore, IQVIA Holdings's EV-to-EBITDA for today is 14.63.
The historical rank and industry rank for IQVIA Holdings's EV-to-EBITDA or its related term are showing as below:
IQV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.45 Med: 18.75 Max: 29.89
Current: 14.63
During the past 13 years, the highest EV-to-EBITDA of IQVIA Holdings was 29.89. The lowest was 11.45. And the median was 18.75.
IQV's EV-to-EBITDA is ranked better than 54.39% of 114
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.34
vs IQV: 14.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
IQVIA Holdings EV-to-EBITDA Historical Data
The historical data trend for IQVIA Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IQVIA Holdings's EV-to-EBITDA
For the Diagnostics & Research subindustry, IQVIA Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IQVIA Holdings's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where IQVIA Holdings's EV-to-EBITDA falls into.
IQVIA Holdings EV-to-EBITDA Calculation
IQVIA Holdings's EV-to-EBITDA for today is calculated as:
IQVIA Holdings's current Enterprise Value is $48,355 Mil.
IQVIA Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,305 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IQVIA Holdings's PE Ratio (TTM) for today is calculated as:
IQVIA Holdings's share price for today is $199.06.
IQVIA Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of IQVIA Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IQV has been successfully added to your 